ABVD regimen: Clinical Trials

5 trials of ABVD regimen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Active not recruiting 1, Terminated 1, Unknown 1

Follow ABVD regimen: new trials by email Literature Review of ABVD regimen trials Research Report on ABVD regimen

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma
bleomycin sulfate, ABVD regimen, carmustine - Lymphoma
Phase 3TerminatedFrench Innovative Leukemia Organisation4422008-05-012016-09-16
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC5522002-08-012025-08-05
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
bleomycin sulfate, ABVD regimen, Stanford V regimen - Lymphoma
Phase 3UnknownMount Vernon Cancer Centre at Mount Vernon Hospital8502001-10-012013-09-20
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
bleomycin sulfate, ABVD regimen, BEACOPP regimen - Lymphoma
Phase 3Active not recruitingEuropean Organisation for Research and Treatment of Cancer - EORTC16491998-10-012025-08-05
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
bleomycin sulfate, ABVD regimen, chlorambucil - Lymphoma
Phase 3CompletedMedical Research Council8001998-06-012013-12-04

Conditions studied

Hodgkin Disease (5)  ·  Lymphoma (5)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  French Innovative Leukemia Organisation (1)  ·  Medical Research Council (1)  ·  Mount Vernon Cancer Centre at Mount Vernon Hospital (1)

Countries

France (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Netherlands (2)  ·  Poland (2)  ·  Spain (2)  ·  Australia (1)  ·  Canada (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Portugal (1)  ·  Slovakia (1)

Top investigators

Anna Sureda (1)  ·  Barry W. Hancock, MD (1)  ·  Bengt Glimelius, MD (1)  ·  Christian Gisselbrecht, MD (1)  ·  Christophe Ferme (1)  ·  David C. Linch (1)  ·  David Ma, MD (1)  ·  Delphine Senecal (1)  ·  Devinder Gill, MD (1)  ·  E.M. Noordijk, MD (1)  ·  H. Eghbali, MD (1)  ·  Jose Thomas, MD (1)  ·  Marine Divine, MD (1)  ·  Patrice P. Carde, MD (1)  ·  Peter J. Hoskin, MD (1)

Results publications

PMID 16314615, PMID 27114593, PMID 28601705, PMID 29229324, PMID 42848781

NIH funding

2004 (1)